Abbott received FDA approval for its Amplatzer Paraclose PVL Occluder, the first transcatheter device designed to close paravalvular leaks around surgical replacement heart valves without requiring additional open-heart surgery.
A U.S. Food and Drug Administration advisory panel voted Wednesday to recommend approval of Grail's Galleri blood test, which screens for more than 50 types of cancer from a single blood sample. Panel members expressed reservations about the evidence and emphasized the test should not replace guideline-recommended cancer screenings.
Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The collapse highlights regulatory risks facing Chinese entrepreneurs expanding globally.
Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The blocked takeover highlights regulatory risks facing Chinese entrepreneurs expanding globally.
DeepHealth, a RadNet subsidiary, received FDA 510(k) clearance for an AI platform that automates breast ultrasound lesion detection, characterization according to ACR BI-RADS standards, and report generation. The technology aims to address the time-intensive, operator-dependent nature of ultrasound breast cancer screening.